These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6494025)

  • 41. Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells.
    Wuthrich RP; Vallotton MB
    Am J Physiol; 1986 Sep; 251(3 Pt 2):F499-505. PubMed ID: 3019160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
    Bankowski K; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice.
    Caldwell JD; Mason GA; Stanley DA; Jerdack G; Hruby VJ; Hill P; Prange AJ; Pedersen CA
    Regul Pept; 1987 Aug; 18(3-4):233-41. PubMed ID: 3671785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix.
    Urban IJ; De Wied D
    Neuropeptides; 1986 Jan; 7(1):41-9. PubMed ID: 3951680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxytocin facilitates the sexual receptivity of estrogen-treated female rats.
    Caldwell JD; Prange AJ; Pedersen CA
    Neuropeptides; 1986; 7(2):175-89. PubMed ID: 3703183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin.
    Kovács GL; Liu B; Burbach JP; Van Ree JM; De Wied D
    Eur J Pharmacol; 1989 Feb; 161(1):27-35. PubMed ID: 2721547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of nitric oxide in systemic vasopressin-induced hypothermia.
    Steiner AA; Carnio EC; Antunes-Rodrigues J; Branco LG
    Am J Physiol; 1998 Oct; 275(4):R937-41. PubMed ID: 9756520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression.
    Thurston CL; Campbell IG; Culhane ES; Carstens E; Watkins LR
    Peptides; 1992; 13(1):17-25. PubMed ID: 1535707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
    Johnson JV; Bennett GW; Hatton R
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors.
    Diamant M; Baars AM; Kovács GL; De Wied D
    Pharmacol Biochem Behav; 1994 Jan; 47(1):27-32. PubMed ID: 8115425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amastatin potentiates the behavioral effects of vasopressin and oxytocin in mice.
    Meisenberg G; Simmons WH
    Peptides; 1984; 5(3):535-9. PubMed ID: 6540873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
    Martínez MC; Vila JM; Aldasoro M; Medina P; Flor B; Lluch S
    Br J Pharmacol; 1994 Oct; 113(2):419-24. PubMed ID: 7834191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The role of paraventricular nucleus of hypothalamus in acupuncture analgesia in rats].
    Chen Y; Wang Y; Yin Q
    Zhen Ci Yan Jiu; 1991; 16(1):32-8. PubMed ID: 1873900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor disturbances and neurotoxicity induced by centrally administered somatostatin and vasopressin in conscious rats: interactive effects of two neuropeptides.
    Balaban CD; Fredericks DA; Wurpel JN; Severs WB
    Brain Res; 1988 Mar; 445(1):117-29. PubMed ID: 2896527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine antagonism does not potentiate the effects of oxytocin and vasopressin on prolactin secretion.
    Pan JT; Mai LM
    Life Sci; 1990; 47(26):2443-50. PubMed ID: 2263168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of vasopressin on the effect of U-50,488 to block the development of morphine tolerance and physical dependence.
    Tao PL; Liu WC; Tsuei YS; Cheng CY
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):281-7. PubMed ID: 9050024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.